Imuracetam
Imuracetam (INN ; developmental code name UCB-G218) is a drug of the racetam group described as a nootropic (cognitive enhancer).[2][3] It was under development in the 1970s but was never marketed.[1] References
|
Imuracetam
Imuracetam (INN ; developmental code name UCB-G218) is a drug of the racetam group described as a nootropic (cognitive enhancer).[2][3] It was under development in the 1970s but was never marketed.[1] References
|